Inscopix is a provider of in vivo cellular imaging solutions. With Inscopix’s nVista HD product, neuroscientists can stream live, high-definition videos of large-scale neural brain activity.
A Stanford spin-off, the core technology and its promise for studying the brain and its diseases have been reported in Nature Medicine (cover story) and Nature Methods. With nVista HD, Inscopix has translated this revolutionary core technology into an end-to-end solution for studying the brain and its diseases.
Inscopix is backed by leading institutional investors including Fidelity Biosciences and the Floodgate Fund.